ALS-ENABLE beamlines played a huge role in the 2020 Nobel Prize in Chemistry awarded to Jennifer Doudna and Emmanuelle Chapentier. Through analysis of data collected at ALS Enable beamlines, Jennifer…
Read more
This virtual workshop will take place on August 9th from 9:00 am – 1:00 pm (PST). If you would like to attend, head over to the ACA site here, register…
Read more
ALS-ENABLE scientist, Jay Nix at the MBC beamline 4.2.2 participated in the structure solution for a recently published paper in Cell, Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading…
Read more
SIBYLS is excited to announce we have a biochemist postdoc fellow opening. This is a great opportunity to work with experienced and innovative scientist in the field of structural biology.…
Read more
ALS-ENABLE beamlines use multiscale, multimodal visualization techniques to clarify how proteins remodel bacterial DNA in response to stressful environments. At the mesoscale, small-angle x-ray scattering (SAXS) at Beamline 12.3.1 made…
Read more
A huge congratulations to the team of Doudna and Charpentier who received the Nobel Prize in Chemistry this year for the development of a new method of genome editing, namely, the much used CRISPR system. Dounda did much of her early structural work on this system using several of the ALS-ENABLE beamlines (though at the time these beamlines were not banded together under the ALS-ENABLE umbrella). We are very proud! Here is a link to a list of publications resulting from work at our beamlines.
Even though we had to hold our BioSAXS workshop virtually this year, it turned out to be one of our best ever. We had more 70 participants over the two…
Read more
The SIBYLS group is holding a virtual workshop and tutorial during the ALS User Meeting. This workshop is designed for current and future SIBYLS and ALS-ENABLE users. We will provide…
Read more
Members of the ALS-ENABLE team helped organize a Bioimaging Forum to discuss current and future bioimaging methods and science at Berkeley Lab. This is the first in a series of…
Read more
Recent Comments